OACCU
Oaktree Acquisition Corp. III Life Sciences
NASDAQ · Financial Services · Asset Management · US
$10.86
−1.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 36.63x
- PEG TTM
- —
- Price / book
- 1.57x
- Price / sales
- —
- Price / cash flow
- -723.65x
Enterprise value
- Enterprise value
- $304.0M
- EV / sales
- —
- EV / EBITDA
- 334.85x
- EV / EBIT
- -254.26x
- Market cap
- $305.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026